The interactions between innate immune responses in mammals and insects on vector-borne disease transmission are poorly understood. This study reveals that host-derived tumor necrosis factor α (TNF-α) binds to the mosquito receptor Wengen (Wgn), promoting the transmission of both rodent and human malaria. This TNF-α/Wgn signaling acts through mosquito TNF receptor-associated factor 3 (mTRAF3), which inhibits mosquito immune deficiency (IMD) pathway-related molecules by targeting transforming growth factor-β-activated kinase 1 (mTAK1), leading to decreased thioester-containing protein 1 (TEP1) production and increased parasite infection in mosquitoes. Additionally, neutralizing host-derived TNF-α by an anti-TNF-α antibody prevents experimental cerebral malaria (ECM) and enhances the effectiveness of an anti-Pfs25 antibody in blocking transmission. Our findings uncover a novel strategy by which host-derived TNF-α can be utilized by the parasite to facilitate its transmission, offering new avenues for preventing cerebral malaria and reducing malaria transmission.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: